Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Peru

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Peru Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20082
20091
20101
20122
20131
20141
20191
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Novartis Pharmaceuticals3
Alliance for Clinical Trials in Oncology1
Amgen1
Checkpoint Therapeutics, Inc.1
Eli Lilly and Company1
R-Pharm1
Regeneron Pharmaceuticals1
Sanofi1
Spectrum Pharmaceuticals, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis16
Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung3
Neoplasms3
Colonic Neoplasms2
Colorectal Neoplasms2
Pancreatic Neoplasms2
Rectal Neoplasms2
Brain Neoplasms1
Breast Diseases1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.